Cp. Paweletz et al., Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip, DRUG DEV R, 49(1), 2000, pp. 34-42
The complicated, changing pattern of protein expression should contain impo
rtant information about the pathologic process taking place in the cells of
actual tissue. Utilization of this information for the selection of drugga
ble targets could be possible if a means existed to rapidly analyze and dis
play changes in protein expression in defined microscopic cellular subpopul
ations. As a demonstration of feasibility, we show the generation of sensit
ive, rapid, and reproducible molecular weight protein profiles of patient-m
atched normal, premalignant, malignant, and metastatic microdissected cell
populations from stained human esophageal, prostate, breast, ovary, colon,
and hepatic tissue sections through the application of an affinity-based bi
ochip. Reproducible, discriminatory protein biomarker profiles can be obtai
ned from as few as 25 cells in less than 5 min from dissection to the gener
ation of the protein fingerprint. Furthermore, these protein pattern profil
es reveal reproducible changes in expression as cells undergo malignant tra
nsformation, and are discriminatory for different tumor types. Consistent p
rotein changes were identified in the microdissected cells from patient-mat
ched tumor and normal epithelium from eight out of eight different malignan
t esophageal tissue sets and three out of three malignant prostate tissue s
ets. A means to rapidly generate a display of expressed proteins from micro
scopic cellular populations sampled from tissue could be an important enabl
ing technology for pharmacoproteomics, molecular pathology, drug interventi
on strategies, therapeutic assessment of drug entities, disease diagnosis,
toxicity, and gene therapy monitoring. Published 2000 Wiley-Liss, Inc.(+)